Age-sex group | Estimated population | Estimated number of infected children | Lower 95% BCI* | Upper 95% BCI* | Model based prevalence | Model-based population adjusted prevalence |
---|---|---|---|---|---|---|
a) Plasmodium sp. | Â | Â | Â | Â | Â | Â |
Boys 5-9 yrs | 1,966,324 | 927,634 | 337,740 | 1,547,775 | 47.7% (4.5) | 47.2% |
Boys 10-14 yrs | 1,587,915 | 607,356 | 190,873 | 1,128,372 | 38.8% (4.3) | 38.2% |
Boys 14-19 yrs | 1,268,729 | 431,452 | 125,464 | 848,679 | 34.6% (4.1) | 34.0% |
Girls 5-9 yrs | 1,956,764 | 607,291 | 163,873 | 1,252,415 | 31.5% (3.5) | 31.0% |
Girls 10-14 yrs | 1,576,155 | 372,161 | 90,670 | 852,659 | 24.1% (3.3) | 23.6% |
Girls 14-19 yrs | 1,247,670 | 254,625 | 55,329 | 614,181 | 21.0% (3.0) | 20.4% |
TOTAL | 9,603,557 | 3,200,519 | 963,949 | 6,244,081 | 33.0% | 33.3% |
b) W. bancrofti | Â | Â | Â | Â | Â | Â |
5-9 yrs | 3,923,088 | 170,668 | 5,027 | 691,754 | 6.7% | 4.4% |
10-14 yrs | 3,164,070 | 202,885 | 8,416 | 733,247 | 9.3% | 6.4% |
14-19 yrs | 2,516,399 | 180,860 | 7,893 | 665,842 | 10.1% | 7.2% |
TOTAL | 9,603,557 | 554,413 | 21,336 | 2,090,843 | 8.7% | 6.0% |